-
公开(公告)号:US20170182054A1
公开(公告)日:2017-06-29
申请号:US15300497
申请日:2015-03-30
发明人: Ottavio ARANCIO , Shixian DENG , Donald W. LANDRY , Jole FIORITO , Rosa PURGATORIO , Owen Anthony O'CONNOR , Jennifer Effie AMENGUAL
IPC分类号: A61K31/536 , C07D265/22 , C07C237/40 , A61K31/166 , C07C235/64 , C07D209/38 , C07D209/34 , A61K31/403 , C07D265/26 , C07C235/42
CPC分类号: A61K31/536 , A61K31/166 , A61K31/403 , A61K2121/00 , C07C235/42 , C07C235/64 , C07C237/40 , C07D209/34 , C07D209/38 , C07D265/22 , C07D265/26
摘要: The invention provides compounds and compositions comprising compounds that modulate histone acyl transferase (HAT). The invention further provides methods for treating neurodegenerative disorders, conditions associated with accumulated amyloid-beta peptide deposits, Tau protein levels, and/or accumulations of alpha-synuclein as well as cancer by administering a compound that modulates HAT to a subject.
-
公开(公告)号:US20180021273A1
公开(公告)日:2018-01-25
申请号:US15655583
申请日:2017-07-20
发明人: Owen Anthony O'CONNOR , Jennifer Effie AMENGUAL , Donald W. LANDRY , Ottavio ARANCIO , Luigi SCOTTO , Shi Xian DENG , Rosa PURGATORIO , Jole FIORITO
IPC分类号: A61K31/167 , A61K38/15 , A61K31/4453 , A61K31/4035
CPC分类号: A61K31/167 , A61K31/18 , A61K31/381 , A61K31/4035 , A61K31/44 , A61K31/4409 , A61K31/4453 , A61K31/495 , A61K31/505 , A61K31/535 , A61K31/5377 , A61K38/15 , A61K45/06 , A61K2300/00
摘要: The invention provides pharmaceutical compositions and methods for treating cancer, neurodegenerative disorders, conditions associated with accumulated amyloid-beta peptide deposits, Tau protein levels, and/or accumulations of alpha-synuclein by administering a HAT modulator and a HDAC modulator to a subject.
-
公开(公告)号:US20210130349A1
公开(公告)日:2021-05-06
申请号:US17137665
申请日:2020-12-30
IPC分类号: C07D471/04 , C07D471/14
摘要: The invention provides for novel benzonaphthyridine derivatives and compositions comprising novel benzonaphthyridine derivatives. In some embodiments, the compounds are phosphodiesterase inhibitors. The invention further provides for methods for inhibition of phosphodiesterase comprising contacting phosphodiesterase with novel benzonaphthyridine derivatives or compositions comprising novel benzonaphthyridine derivatives. The invention further provides for methods for treatment of neurodegenerative diseases, increasing memory or long term potentiation with novel benzonaphthyridine derivatives or compositions comprising novel benzonaphthyridine derivatives. In some embodiments, the phosphodiesterase is PDE5.
-
公开(公告)号:US20180360842A1
公开(公告)日:2018-12-20
申请号:US15868458
申请日:2018-01-11
发明人: Ottavio ARANCIO , Shi Xian DENG , Donald W. LANDRY , Jole FIORITO , Rosa PURGATORIO , Owen Anthony O'CONNOR , Jennifer Effie AMENGUAL
IPC分类号: A61K31/536 , C07C235/64 , C07C235/42 , C07D209/38 , C07D265/26 , C07D265/22 , A61K31/403 , A61K31/166 , C07D209/34 , C07C237/40
摘要: The invention provides compounds and compositions comprising compounds that modulate histone acyl transferase (HAT). The invention further provides methods for treating neurodegenerative disorders, conditions associated with accumulated amyloid-beta peptide deposits, Tau protein levels, and/or accumulations of alpha-synuclein as well as cancer by administering a compound that modulates HAT to a subject.
-
公开(公告)号:US20200330410A1
公开(公告)日:2020-10-22
申请号:US16870584
申请日:2020-05-08
发明人: Owen Anthony O'CONNOR , Jennifer Effie AMENGUAL , Donald W. LANDRY , Ottavio ARANCIO , Luigi SCOTTO , Shixian DENG , Rosa PURGATORIO , Jole FIORITO
IPC分类号: A61K31/167 , A61K31/5377 , A61K31/44 , A61K31/381 , A61K45/06 , A61K31/535 , A61K31/4409 , A61K31/495 , A61K31/505 , A61K31/18 , A61K31/4035 , A61K31/4453 , A61K38/15
摘要: The invention provides pharmaceutical compositions and methods for treating cancer, neurodegenerative disorders, conditions associated with accumulated amyloid-beta peptide deposits, Tau protein levels, and/or accumulations of alpha-synuclein by administering a HAT modulator and a HDAC modulator to a subject.
-
公开(公告)号:US20230165813A1
公开(公告)日:2023-06-01
申请号:US17881340
申请日:2022-08-04
发明人: Owen Anthony O'CONNOR , Jennifer Effie AMENGUAL , Donald W. LANDRY , Ottavio ARANCIO , Luigi SCOTTO , Shixian DENG , Rosa PURGATORIO , Jole FIORITO
IPC分类号: A61K31/167 , A61K31/5377 , A61K31/44 , A61K31/381 , A61K45/06 , A61K31/535 , A61K31/4409 , A61K31/495 , A61K31/505 , A61K31/18 , A61K31/4035 , A61K31/4453 , A61K38/15
CPC分类号: A61K31/167 , A61K31/5377 , A61K31/44 , A61K31/381 , A61K45/06 , A61K31/535 , A61K31/4409 , A61K31/495 , A61K31/505 , A61K31/18 , A61K31/4035 , A61K31/4453 , A61K38/15
摘要: The invention provides pharmaceutical compositions and methods for treating cancer, neurodegenerative disorders, conditions associated with accumulated amyloid-beta peptide deposits, Tau protein levels, and/or accumulations of alpha-synuclein by administering a HAT modulator and a HDAC modulator to a subject.
-
公开(公告)号:US20220127232A1
公开(公告)日:2022-04-28
申请号:US17429049
申请日:2020-02-07
发明人: Ottavio ARANCIO , Elisa ZUCCARELLO , Elisa CALCAGNO , Donald W. LANDRY , Shixian DENG , Jole FIORITO , Luuk Elard DE VRIES , Christopher John YARNOLD , Richard Scott JONES , Julian Hugh ROWLEY
IPC分类号: C07D213/82 , C07C235/44 , C07D213/75 , A61P25/28
摘要: Compounds and compositions comprising compounds that modulate histone acyl transferase (HAT). The invention further provides methods for treating neurodegenerative disorders, conditions associated with accumulated amyloid-beta peptide deposits, Tau protein levels, and/or accumulations of alpha-synuclein as well as cancer by administering a compound that modulates HAT to a subject.
-
公开(公告)号:US20220125748A1
公开(公告)日:2022-04-28
申请号:US17429048
申请日:2020-02-07
发明人: Ottavio ARANCIO , Donald W. LANDRY , Shixian DENG , Jennifer Effie AMENGUAL , Elisa ZUCCARELLO , Jole FIORITO , Yuxuan LIU , Elisa CALCAGNO , Luuk Elard DE VRIES
IPC分类号: A61K31/167 , A61K38/15 , C07C235/56 , A61P25/28
摘要: The invention provides for compounds that are HAT activators or inhibitors. The invention further provides a method for treating neurodegenerative diseases, cancer and other malignant conditions, or to increase memory in a subject not suffering from a neurodegenerative disease by administering HAT activators or inhibitors to a subject in need thereof. The method further comprises co-administration of HD AC inhibitors with HAT activators or HD AC activators with HAT inhibitors.
-
公开(公告)号:US20180244603A1
公开(公告)日:2018-08-30
申请号:US15968524
申请日:2018-05-01
发明人: Yitshak FRANCIS , Mauro FA , Ottavio ARANCIO , Jole FIORITO , Shixian DENG , Donald W. LANDRY , Michal LUZAC , Yan FENG
IPC分类号: C07C217/22 , C07D209/48 , C07D295/088 , C07D265/14
CPC分类号: C07C217/22 , C07C217/58 , C07C235/60 , C07C235/64 , C07C251/24 , C07D209/48 , C07D265/14 , C07D265/36 , C07D295/088
摘要: The invention provides compounds and compositions comprising compounds that modulate histone acyl transferase (HAT). The invention further provides methods for treating neurodegenerative disorders, conditions associated with accumulated amyloid-beta peptide deposits, Tau protein levels and/or accumulations of alpha-synuclein as well as cancer by administering a compound hat modulates HAT to a subject.
-
-
-
-
-
-
-
-